IGMS - IGM Biosciences up 40% following Biogen HI-Bio buy
2024-05-22 11:44:10 ET
More on IGM Biosciences
- IGM Biosciences: Unlikely To Move The Needle Again In 2024
- IGM Biosciences GAAP EPS of -$0.83 misses by $0.01, revenue of $0.5M misses by $0.28M
- IGM Biosciences announces refocusing of Sanofi collaboration
- Seeking Alpha’s Quant Rating on IGM Biosciences
- Historical earnings data for IGM Biosciences